-
A note on including time-dependent covariate in regression model for competin...
Recently, regression analysis of the cumulative incidence function has gained interest in competing risks data analysis, through the model proposed by Fine and Gray... -
ALGOS: the development of a randomized controlled trial testing a case manage...
International audience -
Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana.
International audience -
Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsome...
International audience -
Safety concern between autologous fat graft, mesenchymal stem cell and osteos...
International audience -
[Optimal duration of anticoagulation of venous thromboembolism].
International audience -
[The optimal duration of anticoagulant treatment following pulmonary embolism].
International audience -
Residual vein obstruction to predict the risk of recurrent venous thromboembo...
International audience -
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
International audience -
Baseline imaging after therapy for unprovoked venous thromboembolism: a rando...
International audience -
Serum lipoprotein (a) levels in patients with first unprovoked venous thrombo...
International audience -
Risk of recurrent venous thromboembolism after a first oestrogen-associated e...
International audience -
d-Dimer testing to predict recurrence risk in venous thromboembolism: looking...
International audience -
Venous thrombosis in children.
International audience -
Treatment of deep vein thrombosis.
International audience -
[Optimal duration of anticoagulant treatment of venous thromboembolism].
International audience -
Low molecular weight heparin administered once versus twice daily in patients...
International audience -
Long-term treatment for venous thromboembolism.
International audience -
A comparison of low-molecular-weight heparin with unfractionated heparin for ...
International audience -
Patients with a first symptomatic unprovoked deep vein thrombosis are at high...
International audience
